The Barcelona Science Park is committed to becoming Catalonia’s MedTech company hub Blog Post

The Barcelona Science Park (PCB), a Spain’s leading scientific, technological and business innovation hub in the life sciences field, aims to embark on a new phase of growth, offering more than 1,200 square metres of office space, particularly to companies in the MedTech sector. To promote this ecosystem, it has signed an alliance with GENESIS Biomed. This consultancy firm, based in PCB, has raised more than 60 million euros for its clients since it was founded in May 2017 by Josep Lluis Falcó.

 

A pioneering study conducted by Eugin reveals that women with Covid-19 produce virus-free eggs Blog Post

A study carried out by a team of researchers from Eugin’s Basic Research Laboratory, headquartered in the Barcelona Science Park, published in the  journal Human Reproduction, has, for the first time, analysed the eggs of women diagnosed with Covid-19 detecting no viral material within them. The findings, globally considered ground-breaking and pioneering in the field of assisted reproduction, supports the notion that there would be no vertical transmission of the infection from mother to child via their eggs.

 

SOM Biotech appoints Alain Duguet PhD as Head of Chemical Manufacturing and Control Blog Post

The biotech company SOM Biotech, based in the Barcelona Science Park and specialized in drug development and discovery, has named Alain Duguet as the new head of Chemical Manufacturing and Control. Duguet is an accredited consultant and expert in the definition, management, evaluation and optimization of the production processes of medicines for the pharmaceutical industry. He has worked in the pharmaceutical industry for over three decades for large multinationals, including Sanofi, where he led this area for over 15 years.

 

Judit Cubedo, CEO of GlyCardial, finalist for the EU Prize for Women Innovators 2020 Blog Post

Judit Cubedo, co-founder and CEO of GlyCardial Diagnostics, is one of the twenty-one women selected as finalists for the EU Prize for Women Innovators 2020, an award given annually to the most talented and inspiring entrepreneurs in Europe. The company led by Judit, which is based in the Barcelona Science Park, is conducting a clinical trial to validate the performance of Apo J-Glyc as a novel biomarker for the early detection of Myocardial Ischaemia. The award winners will be announced at the European Research and Innovation Days taking place on 22-24 September 2020.

 

Launch of the company Gate2Brain, based on novel technology developed at IRB Barcelona to transport drugs into the brain Blog Post

The Institute for Research in Biomedicine (IRB Barcelona), the University of Barcelona (UB) and the Sant Joan de Déu Research Institute (IRSJD)- Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel technology to transport drugs into the brain. The biotech, based in the Barcelona Science Park, is the second joint spin-off between IRB Barcelona and the UB to be funded by the Mind the Gap Programme run by the Botín Foundation.

 

Gorka Etxebarria, new Chief Scientific Officer of Nostrum Biodiscovery Blog Post

Nostrum Biodiscovery (NBD) has appointed Dr. Gorka Etxebarria as new Chief Scientific Officer. Dr Etxebarria has a solid career linked to drug discovery projects in the pharmaceutical industry. His incorporation comes after the signing of Ezequiel Mas as new company CEO, to pilot a new stage of growth as a global provider of leading molecular simulation technologies applied to drug discovery and design.

 

The European Union has granted the coordination of three European projects to IBEC Blog Post

The European Union has granted the coordination of three European projects to the Institute for Bioengineering of Catalonia (IBEC) to continue combining medicine, science and technology with the aim of improving people’s health. Among the milestones achieved in recent years by the experts of the Institute, based at the Barcelona Science Park, we can find the development of bioimplants enriched with stem cells or the generation of vascularized mini-kidneys that have helped identify a drug in clinical phase that blocks the effects of SARS-Co-V2.

 

Scientists at CNAG-CRG and CRG develop a new tool to film genome dynamics Blog Post

Scientists from the Centro Nacional de Análisis Genómico (CNAG-CRG) –based in the Barcelona Science Park and integrated into the Centre for Genomic Regulation (CRG)– have developed TADdyn, a tool that can generate movies of how genomes change over time. The finding, published in Nature Communications, will help researchers worldwide learn much more about the direct relationship between structure and function in the genome.